US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

BNTX

BioNTech (BNTX)

BioNTech SE

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BNTX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/17	20 : 18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/06/03	20 : 46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/06/01	23 : 00	Business Wire	Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)	NASDAQ:BNTX	BioNTech SE
2024/06/01	23 : 00	GlobeNewswire Inc.	Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)	NASDAQ:BNTX	BioNTech SE
2024/05/29	21 : 00	GlobeNewswire Inc.	BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem	NASDAQ:BNTX	BioNTech SE
2024/05/27	09 : 00	PR Newswire (US)	MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership	NASDAQ:BNTX	BioNTech SE
2024/05/22	05 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/05/21	19 : 45	GlobeNewswire Inc.	BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024	NASDAQ:BNTX	BioNTech SE
2024/05/18	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/05/18	00 : 15	GlobeNewswire Inc.	BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024	NASDAQ:BNTX	BioNTech SE
2024/05/06	21 : 09	IH Market News	Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise	NASDAQ:BNTX	BioNTech SE
2024/05/06	20 : 18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/05/06	19 : 48	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/05/06	19 : 45	GlobeNewswire Inc.	BioNTech Announces First Quarter 2024 Financial Results and Corporate Update	NASDAQ:BNTX	BioNTech SE
2024/04/26	20 : 48	IH Market News	Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News	NASDAQ:BNTX	BioNTech SE
2024/04/24	20 : 28	IH Market News	Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News	NASDAQ:BNTX	BioNTech SE
2024/04/22	19 : 45	GlobeNewswire Inc.	BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024	NASDAQ:BNTX	BioNTech SE
2024/04/08	03 : 00	GlobeNewswire Inc.	Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer	NASDAQ:BNTX	BioNTech SE
2024/03/21	20 : 17	IH Market News	Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates	NASDAQ:BNTX	BioNTech SE
2024/03/20	20 : 17	IH Market News	U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip	NASDAQ:BNTX	BioNTech SE
2024/03/20	19 : 15	GlobeNewswire Inc.	BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	NASDAQ:BNTX	BioNTech SE
2024/03/20	19 : 00	GlobeNewswire Inc.	BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer	NASDAQ:BNTX	BioNTech SE
2024/03/11	22 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/03/11	20 : 45	GlobeNewswire Inc.	BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024	NASDAQ:BNTX	BioNTech SE
2024/03/11	19 : 25	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTX	NASDAQ:BNTX	BioNTech SE
2024/03/07	22 : 41	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
2024/03/07	20 : 45	GlobeNewswire Inc.	BioNTech Announces Planned Retirement of Sean Marett	NASDAQ:BNTX	BioNTech SE
2024/03/06	20 : 45	GlobeNewswire Inc.	BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024	NASDAQ:BNTX	BioNTech SE
2024/03/05	19 : 45	PR Newswire (US)	The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX	NASDAQ:BNTX	BioNTech SE
2024/02/29	08 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE

Showing the most relevant articles for your search:NASDAQ:BNTX

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Euro

Deutsche Telekom (QX)

Gold vs US Dollar

Verizon Communications

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約